Lercanidipine hydrochloride
PRIMACOR contains the active substance lercanidipine hydrochloride, which belongs to a group of medicines called calcium channel blockers (dihydropyridine derivatives), which lower blood pressure.
PRIMACOR is used to treat high blood pressure (hypertension) in adults over 18 years of age (the medicine is not recommended for use in children under 18 years of age).
clarithromycin)
Before taking PRIMACOR, discuss with your doctor or pharmacist:
Tell your doctor if you are pregnant, think you may be pregnant, or are planning to become pregnant, as well as if you are breastfeeding (see section "Pregnancy, breastfeeding, and fertility").
The safety and efficacy of PRIMACOR in children and adolescents under 18 years of age have not been established.
Tell your doctor or pharmacist about all medicines you are taking now or have taken recently, as well as any medicines you plan to take.
If PRIMACOR is taken with other medicines, its effect or the effect of other medicines may change, and the frequency of side effects may increase (see also section 2, subsection "When not to take PRIMACOR").
In particular, inform your doctor or pharmacist if you are taking any of the following medicines:
PRIMACOR is not recommended during pregnancy and should not be taken during breastfeeding.
There are no data on the use of PRIMACOR in pregnant or breastfeeding women.
If you are pregnant or breastfeeding, if you are not using any contraceptive method, if you think you may be pregnant, or if you plan to become pregnant, consult your doctor or pharmacist before taking this medicine.
If you experience dizziness, weakness, or drowsiness while taking this medicine, do not drive or operate machinery.
If you have been diagnosed with intolerance to some sugars, contact your doctor before taking this medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is considered "sodium-free."
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The recommended dose is 10 mg once daily, taken at the same time every day, preferably in the morning, at least 15 minutes before breakfast. If necessary, your doctor may increase the dose to one 20 mg tablet of PRIMACOR per day (see also section 2, subsection "Taking PRIMACOR with food, drink, and alcohol").
PRIMACOR 10 mg: the score line on the tablet helps to break it, making it easier to swallow, but not to divide it into equal doses.
PRIMACOR 20 mg: the tablet can be divided into equal doses.
Tablets should be swallowed whole with a sufficient amount of water.
Do not give this medicine to children and adolescents under 18 years of age.
No dose adjustment is necessary. However, caution should be exercised at the beginning of treatment.
Caution should be exercised at the beginning of treatment and when increasing the daily dose to 20 mg.
Do not take more than the recommended dose.
If you have taken more than the recommended dose, contact your doctor or go to the emergency department of the nearest hospital immediately. Take the medicine package with you.
Taking more than the recommended dose may cause excessive lowering of blood pressure and irregular or rapid heart rate.
If you forget to take a dose, skip the missed dose and take the next dose at the usual time the next day. Do not take a double dose to make up for the missed dose.
If you stop taking PRIMACOR, your blood pressure may rise again. Before stopping treatment, consult your doctor.
If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects may occur during treatment with this medicine:
Rare (may affect up to 1 in 1000 people):angina (e.g., chest pain caused by insufficient blood flow to the heart), allergic reactions (with symptoms such as itching, rash, hives), fainting.
In patients who have had angina before, taking medicines like PRIMACOR may cause an increase in frequency, duration, or severity of angina attacks. In rare cases, a heart attack may occur.
Common (may affect up to 1 in 10 people):headache, rapid heart rate, palpitations (feeling of rapid or irregular heart rate), sudden reddening of the face, neck, or upper chest, swelling of the ankles.
Uncommon (may affect up to 1 in 100 people):dizziness, low blood pressure, heartburn, nausea, stomach pain, skin rash, itching, muscle pain, frequent urination, weakness, fatigue.
Rare (may affect up to 1 in 1000 people):drowsiness, vomiting, diarrhea, hives, frequent urination, chest pain.
Frequency not known (frequency cannot be estimated from the available data):gum swelling, liver function disorders (detected in blood tests), clouding of the dialysis fluid (during dialysis with a catheter placed in the abdominal cavity), swelling of the face, lips, tongue, or throat, which may cause difficulty breathing or swallowing.
If you experience any side effects, including those not listed in this package leaflet, tell your doctor or pharmacist, or nurse.
Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister after EXP.
The expiry date refers to the last day of the month.
PRIMACOR, 10 mg, coated tablets: Store in the original package to protect from light.
PRIMACOR, 20 mg, coated tablets: Store in the original package to protect from light. Store below 25°C.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
PRIMACOR, 10 mg, coated tablets
PRIMACOR, 20 mg, coated tablets
PRIMACOR, 10 mg: yellow, round, biconvex coated tablets with a diameter of 6.5 mm, with a score line on one side.
PRIMACOR, 10 mg is available in packs of 14, 28, 60, and 90 coated tablets.
Not all pack sizes may be marketed.
PRIMACOR, 20 mg: pink, round, biconvex coated tablets with a diameter of 8.5 mm, with a score line on one side.
PRIMACOR, 20 mg is available in packs of 7, 14, 28, 35, 42, 50, 56, 60, 90, 98, and 100 coated tablets.
Not all pack sizes may be marketed.
Marketing authorization holder (PRIMACOR, 10 mg, coated tablets)
Berlin-Chemie AG
Glienicker Weg 125
12489 Berlin
Germany
Marketing authorization holder (PRIMACOR, 20 mg, coated tablets)
Berlin-Chemie AG
(Menarini Group)
Glienicker Weg 125
12489 Berlin
Germany
Manufacturer
Berlin-Chemie AG
(Menarini Group)
Glienicker Weg 125
12489 Berlin
Germany
or
Recordati Industria Chimica e Farmaceutica S.p.A.
Via Matteo Civitali 1
20148 Milan
Italy
To obtain more detailed information on this medicine, contact the local representative of the marketing authorization holder:
Berlin-Chemie/Menarini Polska Sp. z o.o.
Phone: +48 22 566 21 00
Fax: +48 22 566 21 01
Date of last revision of the package leaflet:24.06.2021
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.